10795--11/23/2007--BECTON_DICKINSON_&

related topics

{regulation, government, change}

{product, liability, claim}

{operation, international, foreign}

{operation, natural, condition}

{customer, product, revenue}

{acquisition, growth, future}

{property, intellectual, protect}

{financial, litigation, operation}

{cost, regulation, environmental}

{product, market, service}

BD s future growth is dependent upon the development of new products, and there can be no assurance that such products will be developed. The medical device industry is very competitive. Inflation and fluctuations in the cost of raw materials could adversely affect the results of our operations. A reduction or interruption in the supply of certain raw materials would adversely affect BD s manufacturing operations and related product sales. Interruption of our manufacturing operations could adversely affect BD s future revenues and operating income. BD is subject to a number of pending lawsuits Consolidation in the healthcare industry could adversely affect BD s future revenues and operating income. Changes in reimbursement practices of third-party payers could affect the demand for our products and the prices at which they are sold. Product defects could adversely affect the results of our operations. BD is subject to extensive regulation. We cannot guarantee that any of BD s strategic acquisitions, investments or alliances will be successful. We are subject to foreign currency exchange risk. The international operations of BD s business may subject BD to certain business risks. Reductions in customers research budgets or government funding may adversely affect our BD Biosciences segment. Our operations are dependent in part on patents and other intellectual property rights. Natural disasters, war or terrorism could adversely affect BD s future revenues and operating income.

Full 10-K form ▸

10795--11/23/2007--BECTON_DICKINSON_&_CO